Agios Pharmaceuticals Inc (NASDAQ:AGIO)

110.44
Delayed Data
As of Jul 02
 +2.69 / +2.50%
Today’s Change
33.01
Today|||52-Week Range
138.85
-1.43%
Year-to-Date

Today’s Trading

Previous close107.75
Today’s open108.18
Day’s range106.89 - 111.51
Volume455,111
Average volume (3 months)702,230
Market cap$4.1B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+43.82%
Earnings growth (this year)-33.66%
Earnings growth (next 5 years)--
Revenue growth (last year)+155.82%
P/E ratioNM
Price/Sales57.71
Price/Book9.72

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc-0.39-0.99%
BRLIBio-Reference Labora...+0.47+1.14%
NVTAInvitae Corp+0.07+0.47%
GNMKGenMark Diagnostics ...+0.16+1.83%
Data as of 4:02pm ET, 07/02/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$65.4M
Annual profit (last year)-$53.5M
Net profit margin-81.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Operating Officer
John Duncan Higgons
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers